Cargando…

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer

Specific microRNA (miRNA) signatures in biological fluids can facilitate earlier detection of the tumors being then minimally invasive diagnostic biomarkers. Circulating miRNAs have also emerged as promising diagnostic biomarkers for colorectal cancer (CRC) screening. In this study, we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herreros-Villanueva, Marta, Duran-Sanchon, Saray, Martín, Ana Carmen, Pérez-Palacios, Rosa, Vila-Navarro, Elena, Marcuello, María, Diaz-Centeno, Mireia, Cubiella, Joaquín, Diez, Maria Soledad, Bujanda, Luis, Lanas, Angel, Jover, Rodrigo, Hernández, Vicent, Quintero, Enrique, José Lozano, Juan, García-Cougil, Marta, Martínez-Arranz, Ibon, Castells, Antoni, Gironella, Meritxell, Arroyo, Rocio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369870/ https://www.ncbi.nlm.nih.gov/pubmed/30702491 http://dx.doi.org/10.14309/ctg.0000000000000003

Ejemplares similares

Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients
por: Duran-Sanchon, Saray, et al.
Publicado: (2019)

Analysis of A 6-Mirna Signature in Serum from Colorectal Cancer Screening Participants as Non-Invasive Biomarkers for Advanced Adenoma and Colorectal Cancer Detection
por: Marcuello, María, et al.
Publicado: (2019)

Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia
por: Vila-Navarro, Elena, et al.
Publicado: (2019)

MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts
por: Vila-Navarro, Elena, et al.
Publicado: (2017)

Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer
por: Bujanda, Luis, et al.
Publicado: (2013)

Pancreatic Cancer in Lynch Syndrome Patients
por: Bujanda, Luis, et al.
Publicado: (2017)

Effect of oral anticoagulants on the outcome of faecal immunochemical test
por: Bujanda, L, et al.
Publicado: (2014)

Current Approaches for Predicting a Lack of Response to Anti-EGFR Therapy in KRAS Wild-Type Patients
por: Er, Tze-Kiong, et al.
Publicado: (2014)

Deciphering microRNA targets in pancreatic cancer using miRComb R package
por: Vila-Casadesús, Maria, et al.
Publicado: (2018)

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples
por: Gallardo-Gómez, María, et al.
Publicado: (2018)

Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer
por: Cubiella, Joaquin, et al.
Publicado: (2018)

MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma
por: Fernandez-Castañer, Elena, et al.
Publicado: (2021)

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
por: Quintero, Enrique, et al.
Publicado: (2016)

Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
por: Gallardo-Gómez, María, et al.
Publicado: (2023)

MiRComb: An R Package to Analyse miRNA-mRNA Interactions. Examples across Five Digestive Cancers
por: Vila-Casadesús, Maria, et al.
Publicado: (2016)

Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012)

Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs
por: De Chiara, Loretta, et al.
Publicado: (2022)

MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics
por: Vila-Navarro, Elena, et al.
Publicado: (2020)

Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
por: Herrero, Jesús-Miguel, et al.
Publicado: (2018)

Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
por: Cosme, Angel, et al.
Publicado: (2017)

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
por: Cubiella, Joaquín, et al.
Publicado: (2016)

HIV Epidemiology in Uganda: survey based on age, gender, number of sexual partners and frequency of testing
por: Vithalani, Jay, et al.
Publicado: (2018)

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
por: González-López, Natalia, et al.
Publicado: (2023)

Role of Dairy Foods, Fish, White Meat, and Eggs in the Prevention of Colorectal Cancer: A Systematic Review of Observational Studies in 2018–2022
por: Alegria-Lertxundi, Iker, et al.
Publicado: (2022)

Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
por: Lanas, Ángel, et al.
Publicado: (2023)

Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma
por: Aguiar-Bujanda, David, et al.
Publicado: (2015)

Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer
por: Otero-Estévez, Olalla, et al.
Publicado: (2016)

Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
por: Clos-Garcia, Marc, et al.
Publicado: (2020)

A Novel Approach on the Use of Samples from Faecal Occult Blood Screening Kits for Metabolomics Analysis: Application in Colorectal Cancer Population
por: Albóniga, Oihane E., et al.
Publicado: (2023)

TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status
por: Herreros-Villanueva, Marta, et al.
Publicado: (2010)

The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer
por: Esteban-Jurado, Clara, et al.
Publicado: (2016)

Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening
por: Otero-Estévez, Olalla, et al.
Publicado: (2015)

Increased Th17-Related Cytokine Serum Levels in Patients With Multiple Polyps of Unexplained Origin
por: Alustiza, Miren, et al.
Publicado: (2020)

Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study
por: Pin‐Vieito, Noel, et al.
Publicado: (2021)

Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis
por: Quintanilla, Isabel, et al.
Publicado: (2022)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
por: Boces-Pascual, Clara, et al.
Publicado: (2021)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome
por: Picó, María Dolores, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9dd2ksnnt8m86qb7908ngna8jb